9A60 - Conjunctivitis: Complete ICD-11 Coding Guide

1. Introduction

Conjunctivitis represents one of the most frequent ophthalmological conditions in daily clinical practice, characterized by inflammation of the conjunctiva, the transparent mucous membrane that lines the inner surface of the eyelids and the anterior portion of the eyeball. This condition affects millions of people annually worldwide, crossing all age groups and socioeconomic contexts.

The clinical importance of conjunctivitis transcends its apparent simplicity. Although often considered a benign and self-limited condition, it can cause significant discomfort, impact work and school productivity, and in some cases, progress to complications that compromise vision. The high transmissibility of certain forms of conjunctivitis, particularly viral forms, represents a significant challenge for public health, generating outbreaks in collective settings such as schools, daycare centers, and workplaces.

From an epidemiological perspective, conjunctivitis is responsible for a substantial portion of ophthalmological and primary care consultations. Its presentation can range from mild and transitory forms to severe manifestations that require urgent specialized intervention. The etiological diversity - including infectious causes (viral, bacterial), allergic, irritative, and autoimmune - makes a careful diagnostic approach essential.

Appropriate coding of conjunctivitis in the ICD-11 system is fundamental for multiple purposes: accurate epidemiological surveillance, public health resource planning, pharmacoepidemiological studies, health information system management, and appropriate reimbursement of medical procedures. Code 9A60 serves as a comprehensive category for the various forms of conjunctivitis, facilitating the standardization of clinical data on a global scale.

2. Correct ICD-11 Code

Code: 9A60

Description: Conjunctivitis

Parent category: Disorders of the conjunctiva

The code 9A60 in the International Classification of Diseases, 11th Revision (ICD-11), represents the main diagnostic category for conjunctivitis in its various forms. This code is positioned within the hierarchical structure of ophthalmological disorders, specifically under the chapter of diseases of the visual system.

The structure of the code reflects the systematic approach of ICD-11 in organizing related conditions in a logical and clinically relevant manner. The code 9A60 functions as a broad category that encompasses different subtypes of conjunctivitis, allowing for additional specifications through complementary codes when necessary.

This coding facilitates communication among health professionals in international contexts, allowing clinical data to be compared and analyzed regardless of language barriers or differences in health systems. The standardization provided by code 9A60 is essential for multicenter research, meta-analyses, and development of evidence-based clinical guidelines.

The correct implementation of this code requires understanding not only the clinical condition, but also the nuances of ICD-11 classification, including when to use more specific subcategory codes and when the generic code 9A60 is most appropriate.

3. When to Use This Code

The code 9A60 should be applied in specific clinical situations where conjunctivitis is the confirmed or highly probable diagnosis. Below are detailed practical scenarios:

Scenario 1: Acute Viral Conjunctivitis Patient presents with bilateral conjunctival hyperemia, abundant watery discharge, foreign body sensation, and history of recent contact with a person with similar symptoms. Examination reveals conjunctival follicles, mild palpebral edema, and absence of corneal involvement. The presentation is typical of viral conjunctivitis, frequently caused by adenovirus. In this context, code 9A60 is appropriate and may be supplemented with codes for etiologic agent when identified.

Scenario 2: Acute Bacterial Conjunctivitis Child presents with thick purulent discharge, yellowish-green in color, with morning crusts that impede eye opening. The tarsal and bulbar conjunctiva show intense hyperemia, but the cornea remains clear on examination with fluorescein. There are no signs of systemic involvement. This classic presentation of bacterial conjunctivitis justifies the use of code 9A60, especially when empiric treatment is initiated without microbiological culture.

Scenario 3: Seasonal Allergic Conjunctivitis Young adult reports recurrent episodes of intense ocular pruritus, tearing, and bilateral conjunctival hyperemia, coinciding with specific periods of the year. Examination reveals papillary hypertrophy on the superior tarsal conjunctiva, conjunctival edema (chemosis), and absence of purulent discharge. Personal history of allergic rhinitis corroborates the diagnosis. Code 9A60 is appropriate for this presentation of allergic conjunctivitis.

Scenario 4: Chemical Irritant Conjunctivitis Worker accidentally exposed to chemical vapors in the occupational environment develops immediate bilateral conjunctival hyperemia, profuse tearing, and burning sensation. After copious irrigation, examination reveals diffuse hyperemia without corneal ulceration or involvement of deeper structures. This chemical irritant conjunctivitis is appropriately coded as 9A60, with additional codes for external cause.

Scenario 5: Chronic Nonspecific Conjunctivitis Elderly patient with prolonged history of mild ocular discomfort, intermittent hyperemia, and sensation of dryness. Examination shows persistent mild conjunctival hyperemia without specific characteristics of viral, bacterial, or allergic etiology. After exclusion of other specific causes, the diagnosis of chronic nonspecific conjunctivitis justifies code 9A60.

Scenario 6: Neonatal Conjunctivitis (Neonatal Ophthalmia) Newborn develops purulent ocular discharge and palpebral edema in the first weeks of life. Examination reveals conjunctivitis with mucopurulent discharge. After collection of material for culture and exclusion of corneal involvement, code 9A60 is applicable, frequently with additional specifiers for etiology when identified (gonococcal, chlamydial, chemical).

4. When NOT to Use This Code

Appropriate distinction between conditions that should and should not be coded as 9A60 is fundamental for diagnostic accuracy:

Keratoconjunctivitis When there is simultaneous involvement of the cornea and conjunctiva, with evidence of keratitis (corneal infiltrates, ulcers, significant epithelial defects), the appropriate code is not 9A60. In these situations, a specific code for keratoconjunctivitis should be used. The presence of intense photophobia, reduced visual acuity, positive fluorescein staining of the cornea, and stromal infiltrates indicate associated keratitis, excluding the isolated use of code 9A60.

Blepharoconjunctivitis When inflammation predominantly involves the eyelid margins in addition to the conjunctiva, with crusting at the base of the eyelashes, marginal telangectasias, and Meibomian gland dysfunction, the condition should be coded as blepharitis or blepharoconjunctivitis, not simply as conjunctivitis.

Scleritis and Episcleritis Inflammation of the sclera or episclera can mimic conjunctivitis but presents distinct characteristics: deep and intense ocular pain (scleritis), hyperemia that does not resolve with topical vasoconstrictors, engorged deep blood vessels, and possible visual compromise. These conditions require specific codes and should not be classified as 9A60.

Anterior Uveitis with Conjunctival Hyperemia The presence of cells and flare in the anterior chamber, ciliary hyperemia (perilimbal), posterior synechiae, or keratic precipitates indicates anterior uveitis, not conjunctivitis. Although secondary conjunctival hyperemia may be present, the primary diagnosis is uveitis, requiring appropriate coding.

Acute Glaucoma Acute angle-closure glaucoma may present with conjunctival hyperemia but is accompanied by intense pain, colored halos, mid-dilated fixed pupil, corneal edema, and elevated intraocular pressure. This ophthalmologic emergency should not be confused with conjunctivitis.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The diagnosis of conjunctivitis is based primarily on clinical evaluation. Begin with a detailed history investigating: symptom onset (acute or gradual), laterality (unilateral or bilateral), type of discharge (watery, mucoidal, purulent), associated symptoms (itching, pain, photophobia), exposure history (sick contacts, allergens, chemicals), and systemic conditions.

Physical examination should include: external inspection of eyelids and eyelashes, evaluation of discharge regarding quantity and characteristics, eyelid eversion to examine tarsal conjunctiva (presence of follicles or papillae), examination of bulbar conjunctiva (hyperemia, chemosis, hemorrhages), corneal evaluation with fluorescein to exclude keratitis, and visual acuity testing.

Essential instruments include: slit lamp (when available) for detailed examination, fluorescein to assess corneal integrity, and occasionally microbiological culture or conjunctival scraping in specific cases. Most cases of conjunctivitis are diagnosed clinically without need for laboratory tests.

Step 2: Verify Specifiers

After confirming the diagnosis of conjunctivitis, determine specific characteristics that may require additional coding:

Duration: Classify as acute (less than 4 weeks) or chronic (more than 4 weeks). Acute conjunctivitis is more common and generally infectious or allergic, while chronic forms may indicate specific etiologies or underlying conditions.

Etiology: When possible, identify the cause: viral (usually adenovirus), bacterial (Staphylococcus, Streptococcus, Haemophilus), allergic (seasonal or perennial), irritative (chemical, physical), or related to systemic conditions. This information may justify complementary codes.

Severity: Assess functional impact and intensity of clinical signs. Mild conjunctivitis presents minimal hyperemia and tolerable discomfort, while severe forms may have extensive chemosis, abundant discharge, and significant functional limitation.

Laterality: Document whether unilateral or bilateral. Viral and allergic conjunctivitis tend to be bilateral, while bacterial forms may begin unilaterally.

Step 3: Differentiate from Other Codes

9A61: Some specified disorders of the conjunctiva This code is reserved for specific conjunctival conditions that do not fit the general category of conjunctivitis. The fundamental difference is that 9A61 encompasses structural or degenerative changes of the conjunctiva (such as pterygium, pinguecula, conjunctival cysts, specific degenerations) that are not primarily inflammatory or infectious. If the patient presents with typical conjunctival inflammation, use 9A60; if presenting with structural alteration without acute inflammatory process, consider 9A61.

9A62: Mucous membrane pemphigoid with ocular involvement This is a rare and severe autoimmune condition affecting mucous membranes, including the conjunctiva. It differs from common conjunctivitis by presenting with subepithelial blister formation, progressive scarring, symblepharon (adhesions between bulbar and tarsal conjunctiva), and potential progression to blindness. Diagnosis requires biopsy with immunofluorescence. If pemphigoid is suspected or confirmed, use 9A62, not 9A60.

Conjunctival neoplasms Tumoral lesions of the conjunctiva (benign or malignant) such as squamous cell carcinoma, melanoma, lymphoma, or papilloma require specific neoplasm codes. Although they may cause secondary hyperemia, the presence of mass, elevated lesion, anomalous vascularization, or suspicious characteristics on examination indicates need for neoplasm investigation, and should not be coded simply as conjunctivitis.

Step 4: Required Documentation

For appropriate coding with 9A60, document:

Mandatory checklist:

Date of symptom onset and duration
Laterality (right, left, or bilateral)
Discharge characteristics (type, quantity, color)
Associated symptoms (itching, pain, photophobia, tearing)
Physical examination findings (hyperemia, chemosis, follicles, papillae)
Corneal status (clear or compromised)
Visual acuity
Presumed or confirmed etiology
Relevant exposures (contacts, allergens, chemicals)
Treatment instituted
Relevant ophthalmologic or systemic comorbidities

This complete documentation not only justifies coding but also facilitates follow-up, allows assessment of therapeutic response, and provides data for epidemiological analyses.

6. Complete Practical Example

Clinical Case:

A 28-year-old female patient, a teacher, seeks medical care with a complaint of "red eyes and tearing" for 3 days. She reports that symptoms started in the right eye with a sensation of grittiness, intense tearing, and progressive hyperemia. The following day, the left eye developed similar symptoms. She denies intense ocular pain or significant photophobia, but reports discomfort that worsens with blinking. She mentions watery discharge, without formation of morning crusts. She mentions that several students in her class presented with a similar condition the previous week.

Past medical history: no significant comorbidities, does not use contact lenses, denies known allergies. Does not use regular medications.

Physical Examination:

Visual acuity: 20/20 in both eyes without correction
External inspection: mild bilateral palpebral edema, without skin lesions
Conjunctiva: diffuse bilateral hyperemia, more intense in the bulbar conjunctiva, presence of follicles in the inferior tarsal conjunctiva bilaterally, scant watery discharge
Cornea: fluorescein test negative bilaterally, transparent, without infiltrates
Anterior chamber: deep, without cells or flare
Pupil: isocoric, photoreactive
Preauricular lymph node: palpable and discretely enlarged on the right

Diagnostic Reasoning:

The clinical presentation is highly suggestive of viral conjunctivitis. The elements that support this diagnosis include: unilateral onset with progression to bilateral, watery discharge (not purulent), presence of conjunctival follicles, epidemiological history of contact with similar cases, and palpable preauricular lymph node. The absence of corneal involvement excludes keratoconjunctivitis, and the absence of intense itching makes allergic conjunctivitis less likely. The non-purulent nature of the discharge and the presence of follicles (not papillae) differentiate it from bacterial conjunctivitis.

Coding Step by Step:

Analysis of criteria:

Confirmed inflammatory process of the conjunctiva: hyperemia, follicles, discharge
Cornea not compromised: excludes keratoconjunctivitis
Absence of involvement of other ocular structures: excludes uveitis, scleritis
Acute presentation (3 days): not a chronic condition
Clinical and epidemiological pattern consistent with viral etiology

Code chosen: 9A60 - Conjunctivitis

Complete Justification: The code 9A60 is appropriate because the primary diagnosis is acute viral conjunctivitis, without involvement of other ocular structures. The condition fits perfectly within the definition of conjunctivitis: inflammation of the conjunctiva with hyperemia, discharge, and discomfort, without signs of keratitis, uveitis, or other complications that would require alternative codes.

Applicable complementary codes:

Code for etiological agent: if specific testing confirmed adenovirus, an additional code could be included
Code for external cause: not applicable in this case (no trauma or chemical exposure)
Code for laterality: bilateral

Management: Guidance on hygiene measures to prevent transmission, cold compresses, artificial tears, and follow-up. Explained that the condition is self-limited, with expected resolution in 1-2 weeks. Advised to return if she develops intense pain, photophobia, or visual reduction.

7. Related Codes and Differentiation

Within the Same Category:

9A61: Some specified disorders of the conjunctiva

When to use vs. 9A60: Code 9A61 is reserved for structural, degenerative, or specific conjunctival conditions that do not constitute typical inflammatory processes of conjunctivitis. Examples include pterygium (fibrovascular growth of the conjunctiva over the cornea), pinguecula (yellowish degeneration of the conjunctiva), conjunctival cysts, conjunctival concretions, and specific degenerations.

Main difference: While 9A60 codes conjunctival inflammation (dynamic process with hyperemia, discharge, and acute symptoms), 9A61 codes persistent anatomical or degenerative changes. A patient with pterygium may develop secondary conjunctivitis; in this case, both codes may be appropriate, with 9A61 as the primary diagnosis (structural condition) and 9A60 as secondary (superimposed acute inflammatory process).

9A62: Mucous membrane pemphigoid with ocular involvement

When to use vs. 9A60: This code is specific for a rare and severe autoimmune disease characterized by subepithelial blister formation and progressive scarring of mucous membranes, including the conjunctiva. Diagnosis requires histopathological confirmation with direct immunofluorescence showing linear immunoglobulin deposition in the basement membrane zone.

Main difference: Mucous membrane pemphigoid is a chronic and progressive systemic disease with potential to cause blindness through severe conjunctival scarring, symblepharon formation, cicatricial entropion, and keratinization of the ocular surface. It differs radically from common conjunctivitis (9A60) by its autoimmune nature, inexorable progression, need for systemic immunosuppression, and guarded prognosis. If clinical suspicion of pemphigoid exists (blisters, scarring, symblepharon), biopsy should be performed and, if confirmed, use 9A62 exclusively.

Neoplasms of the conjunctiva

When to use vs. 9A60: Specific codes for conjunctival neoplasms should be used when there is a tumor mass, elevated pigmented or non-pigmented lesion, progressive growth, atypical vascularization, or characteristics suspicious for malignancy. Common neoplasms include squamous cell carcinoma, melanoma, conjunctival lymphoma, papilloma, and nevi.

Main difference: Neoplasms present abnormal tissue growth, while conjunctivitis is a reversible inflammatory process. A visible conjunctival mass, especially if unilateral, progressive, and with atypical vascular characteristics, requires investigation for neoplasia. Localized hyperemia adjacent to a tumor lesion should not be coded as conjunctivitis; the neoplasm code takes priority.

Differential Diagnoses:

Red eye from acute glaucoma: Differentiated by severe pain, elevated intraocular pressure, corneal edema, shallow anterior chamber, and fixed mid-dilated pupil. Requires specific glaucoma code.

Anterior uveitis: Presents with ciliary hyperemia (perilimbal), cells in the anterior chamber, ocular pain, and photophobia. Should not be confused with conjunctivitis.

Subconjunctival hemorrhage: Bright red blood under the conjunctiva, without discharge or significant discomfort. Requires specific code, not 9A60.

8. Differences with ICD-10

In the International Classification of Diseases, 10th Revision (ICD-10), conjunctivitis was coded primarily under category H10, with multiple specific subdivisions based on etiology and clinical characteristics. For example: H10.0 (Mucopurulent conjunctivitis), H10.1 (Acute atopic conjunctivitis), H10.2 (Other acute conjunctivitis), H10.4 (Chronic conjunctivitis), among others.

The transition to ICD-11 with code 9A60 represents a significant structural reorganization. ICD-11 adopts a more simplified approach in the main category, allowing additional specifications through extension codes and qualifiers, rather than multiple separate codes for each etiological variant.

Main changes:

Simplification of structure: ICD-11 consolidates several subdivisions from ICD-10 under the single code 9A60, with the possibility of specification through extensions.
Greater flexibility: ICD-11's post-coordination system allows adding details about etiology, severity, and laterality without the need for completely different codes.
Alignment with clinical practice: ICD-11's structure better reflects how clinicians think about conjunctivitis: first as a diagnostic category, then with specifications.

Practical impact: Professionals accustomed to ICD-10 will need to adapt to the new structure, understanding that the main code 9A60 may be sufficient in many contexts, with additional specifications added as needed and available in the information system used. This change may simplify coding in some scenarios, but requires training for proper use of ICD-11 qualifiers.

9. Frequently Asked Questions

1. How is conjunctivitis diagnosed?

The diagnosis of conjunctivitis is predominantly clinical, based on detailed history and ophthalmologic physical examination. The physician investigates symptoms such as hyperemia, discharge, tearing, pruritus, and discomfort, in addition to examining the appearance of the conjunctiva, type of discharge, and corneal status. In most cases, laboratory tests are not necessary. Microbiological cultures or conjunctival scrapings are reserved for severe cases, recurrent cases, those that do not respond to empiric treatment, or in neonates. Slit lamp examination allows detailed evaluation, differentiating conjunctivitis from more serious conditions such as keratitis or uveitis.

2. Is treatment available in public health systems?

Treatment of conjunctivitis is generally available in public health systems, as it involves relatively accessible and well-established medications. Viral conjunctivitis, being self-limited, requires mainly supportive treatment with artificial tears and cold compresses, both of low cost. Bacterial conjunctivitis is treated with topical antibiotics (eye drops or ointments), medications widely available in basic drug formularies. Allergic conjunctivitis may require topical antihistamines or mast cell stabilizers, also frequently available. Most cases can be managed at the primary care level, without need for specialist referral or sophisticated technologies.

3. How long does treatment last?

The duration of treatment varies according to the etiology of conjunctivitis. Viral conjunctivitis is self-limited, typically resolving in 1-3 weeks without specific treatment, although supportive measures may be maintained throughout this period. Bacterial conjunctivitis, when treated with appropriate topical antibiotics, generally improves in 3-5 days, with complete treatment lasting 5-7 days. Allergic conjunctivitis requires continuous treatment while there is exposure to the allergen, which may be seasonal (weeks to months) or perennial (prolonged treatment). Chronic forms may require intermittent or continuous treatment for extended periods, depending on the underlying cause. It is essential to complete the prescribed course of antibiotics even with early improvement of symptoms.

4. Can this code be used in medical certificates?

Yes, code 9A60 can and should be used in medical certificates when conjunctivitis is the established diagnosis. The inclusion of the ICD code facilitates standardized communication between health professionals, institutions, and information systems. In certificates for work or school absence, especially in cases of infectious conjunctivitis, the code formally documents the condition justifying temporary absence to prevent transmission. The duration of absence should be determined clinically: contagious viral conjunctivitis may require 5-7 days of absence, while adequately treated bacterial forms may allow return after 24-48 hours of antibiotic therapy, when purulent discharge has ceased.

5. Does conjunctivitis always require treatment with antibiotics?

No. This is a common misconception. Viral conjunctivitis, which represents a significant proportion of cases, does not benefit from antibiotics and is treated only with supportive measures. Indiscriminate use of antibiotics in viral conjunctivitis contributes to bacterial resistance without clinical benefit. Allergic conjunctivitis requires antihistamines or mast cell stabilizers, not antibiotics. Only proven or strongly suspected bacterial conjunctivitis benefits from topical antibiotic therapy. The decision to prescribe antibiotics should be based on clinical characteristics: thick purulent discharge, absence of follicles, unilateral onset, and absence of viral epidemiologic history suggest bacterial etiology justifying antibiotics.

6. Can conjunctivitis cause vision loss?

Simple conjunctivitis, coded as 9A60, rarely causes permanent visual loss. The conjunctiva is a superficial membrane and its isolated inflammation does not affect critical optical structures. However, some specific forms of conjunctivitis may progress with complications: conjunctivitis caused by Neisseria gonorrhoeae in neonates can perforate the cornea if not treated urgently; adenovirus conjunctivitis can develop subepithelial corneal infiltrates causing temporary visual reduction; conjunctivitis associated with mucous membrane pemphigoid can progress to scarring and blindness. When there is corneal involvement, the condition progresses to keratoconjunctivitis, requiring a different code. Visual reduction during simple conjunctivitis is generally transient, caused by discharge or mild edema, resolving completely with treatment.

7. When is referral to an ophthalmologist necessary?

Referral for specialized ophthalmologic evaluation is indicated in specific situations: reduction in visual acuity that does not improve after discharge cleaning; intense ocular pain disproportionate to the clinical presentation; significant photophobia; suspected corneal involvement (positive fluorescein test); conjunctivitis in contact lens users (risk of severe bacterial keratitis); neonatal conjunctivitis (risk of serious complications); lack of response to appropriate treatment in 5-7 days; recurrent or chronic conjunctivitis without apparent cause; presence of atypical signs such as conjunctival mass, extensive hemorrhage, or structural alterations; and immunocompromised patients with conjunctivitis. These scenarios suggest more complex conditions that may require additional investigation, specialized treatments, or exclusion of serious diagnoses.

8. Is conjunctivitis always contagious?

No. Contagiousness depends on the etiology. Viral and bacterial conjunctivitis are highly contagious, transmitted through direct contact with ocular secretions, contaminated fomites, or respiratory droplets (in some viruses). Rigorous hygiene measures are essential: frequent hand washing, avoiding touching the eyes, not sharing towels or pillows, and temporary absence from collective environments. In contrast, allergic conjunctivitis is not contagious, resulting from individual immunologic response to environmental allergens. Conjunctivitis from chemical or physical irritants is also not transmissible. The distinction between contagious and non-contagious forms is important for appropriate guidance on precautions and need for social or occupational absence.

Conclusion:

ICD-11 code 9A60 for conjunctivitis represents an essential tool in the standardized coding of one of the most prevalent ophthalmologic conditions globally. The correct application of this code requires clinical understanding of the condition, ability to differentiate it from other ocular disorders, and knowledge of the hierarchical structure of ICD-11. This guide provides health professionals with the necessary information for accurate coding, contributing to reliable epidemiologic data, appropriate health system management, and fundamentally, better care for patients with conjunctivitis.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-02

Conjunctivitis

Partager